Swain, S. “2-Hour 75 Gm OGTT for Screening and Rescreening at 32-34 Weeks for Diagnosing Gestational Diabetes-Evaluation of Maternal and Neonatal Outcomes”. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, vol. 6, no. 7, June 2017, pp. 2926-32, doi:10.18203/2320-1770.ijrcog20172909.